|
|
Volumn 6, Issue 3, 2005, Pages 174-177
|
|
Dextromethorphan/Quinidine AVP 923, dextromethorphan/cytochrome P450-2D6 inhibitor, quinidine/dextromethorphan
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
AVP 923;
CYTOCHROME P450 2D6;
CYTOCHROME P450 INHIBITOR;
DEXTROMETHORPHAN;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NARCOTIC AGENT;
NEURODEX;
QUINIDINE;
CHRONIC DISEASE;
CLINICAL TRIAL;
COUGHING;
DIABETIC NEUROPATHY;
DIARRHEA;
DIZZINESS;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG DEPENDENCE;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG MECHANISM;
EMOTIONAL DISORDER;
EUROPE;
FIRST PASS EFFECT;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL DISEASE;
HUMAN;
ISRAEL;
JAPAN;
LICENSING;
MULTIPLE SCLEROSIS;
NAUSEA;
NEUROPATHIC PAIN;
OXIDATION;
PAIN ASSESSMENT;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
SCORING SYSTEM;
SIDE EFFECT;
SOMNOLENCE;
TIME;
TREATMENT INDICATION;
UNITED STATES;
CLINICAL TRIALS;
CYTOCHROME P-450 CYP2D6;
DEXTROMETHORPHAN;
DRUG COMBINATIONS;
DRUG SYNERGISM;
DRUGS, INVESTIGATIONAL;
HUMANS;
QUINIDINE;
RECEPTORS, N-METHYL-D-ASPARTATE;
RECEPTORS, SIGMA;
|
|
EID: 22244469039
PISSN: 11745886
EISSN: None
Source Type: Journal
DOI: 10.2165/00126839-200506030-00006 Document Type: Review |
|
Times cited : (5)
|
|
References (8)
|
